Evidence map›Paper›PMID 23598977›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2013

Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells.

Kevin C Ess

Abstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Cellular reprogramming for understanding and treating human disease.Frontiers in cell and developmental biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kevin C EssDepartment of Neurology, Vanderbilt Kennedy Center, Vanderbilt Center for Stem Cell Biology, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. kevin.ess@vanderbilt.edu

Funding

Regulation of Neurogenesis in TSC by mTORC1 and mTORC2R01NS078289 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ESS, KEVIN C · 2012 to 2016
$1.7M
NINDS NIH HHS R01 NS078289
6 · The paper itself

Abstract

Disorders of the brain and spinal cord are common worldwide problems but have remained very difficult to treat. As a group they have diverse etiologies and can be due to trauma, infection, tumors, genetic mutations and environmental insults. Though distinct in etiology, neurological disorders share an overall intractability as current therapies are largely limited to treatment of symptoms. Improved outcomes are further constrained by the minimal endogenous capacity of the brain and spinal cord for repair. Spectacular recent scientific advances, however, suggest that new stem cell-based approaches may change this undesirable situation. In this review, I will broadly outline the challenges of studying and treating disorders of the brain and spinal cord. I will review ongoing attempts to use stem cell-based therapies to both model and treat neurological disorders. While this field is in its infancy, expected advances and needed breakthroughs point to a future where patient-derived stem cells will be the basis for the emerging discipline of regenerative neurology.

Indexed as

Cell Culture TechniquesCell DifferentiationEpilepsyHumansInduced Pluripotent Stem CellsMesenchymal Stem Cell TransplantationNervous System DiseasesRegenerative MedicineSpinal Cord InjuriesStem Cell Transplantation

Identifiers

PMID23598977
PMCPMC3784026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.